Synagistics Limited — Board/Management Information 2022

Jan 4, 2022

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [63 x 86] intentionally omitted <==

WEALTHKING INVESTMENTS LIMITED 華 科 資 本 有 限 公 司

(Incorporated in the Cayman Islands with limited liability) (Stock Code: 1140)

SUPPLEMENTAL ANNOUNCEMENT CHANGE OF CHIEF EXECUTIVE OFFICER

Reference is made to the announcement (the ‘‘Announcement’’) of Wealthking Investments Limited (the ‘‘Company’’) dated 29 December 2021 in relation to the change of chief executive officer of the Company. Unless otherwise stated, capitalized terms use herein shall have the same meaning as those defined in the Announcement.

The Company would like to supplement that Dr. Zhu resigned as the chief executive officer of the Company due to personal reason. As mentioned in our announcement issued on 31 December 2020, the roles and responsibilities of Dr. Zhu as the chief executive officer of the Company included overseeing the day-to-day running in accordance with the business plans and within the budgets approved by the Board, and organizing the implementation of the strategies and policies as approved by the Board and its committees. Due to the continuation of COVID-19 pandemic, cross border travelling between Mainland China and Hong Kong has been subject to mandatory quarantine. As a result of the aforementioned, Dr. Zhu encountered difficulties in discharging those roles and responsibilities effectively. Dr. Zhu has indicated to the Company that he wished to focus on other career development.

In addition, Dr. Liu is currently receiving a director’s fee of HK$250,000 per annum pursuant to the service contract entered into between the Company and Dr. Liu in relation to his appointment as an executive Director. The remuneration of Dr. Liu was determined by the Board with reference to his duties and responsibilities within the Company, and by reference to the prevailing market conditions of companies of comparable size and similar operations. There is no additional remuneration payable to Dr. Liu for acting as the chairman of the Board and director of various subsidiaries of the Company.

– 1 –

Save as the clarification above, the other information contained in the Announcement remains unchanged.

By Order of the Board Wealthking Investments Limited Liu Zhiwei Executive Director and Chairman

Hong Kong SAR, 4 January 2022

As at the date of this announcement, the Board comprises one executive Director, namely, Dr. Liu Zhiwei; two non-executive Directors, namely Dr. Fu Weigang and Dr. Wang Shibin; and three independent non-executive Directors, namely, Professor He Jia, Mr. Wang Xiaojun and Mr. Chen Yuming.

– 2 –